Pfizer Inc, the No. 1 U.S. drugmaker, and Botox maker Allergan Plc said they were in friendly talks to create a pharmaceutical colossus but the prospect that the company would seek to avoid U.S. taxes sounded political alarm bells.
Both New York-based Pfizer and Dublin-based Allergan said no agreement has been reached and declined to discuss any terms of the deal, which would potentially set up Pfizer to take advantage of Ireland's lower tax rates.
01:02 A company Trump attacked will receive state tax breaks to keep jobs in the U.S11
20:37 Brazil grants antitrust approval for FMC Technologies, Technip merger18
18:05 DP World, Quebec's Caisse to create C$5 billion investment vehicle12
14:45 Spain raises taxes to try to meet EU deficit target13